Flow Traders U.S.’s iShares Biotechnology ETF IBB Stock Holding History

Flow Traders U.S.’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.5M	Buy	20,708 +13,701	+196%	+$2.34M	0.11%	155
2025 Q4	$1.18M	Sell	7,007 -23,069	-77%	-$3.75M	0.04%	348
2025 Q3	$4.34M	Buy	+30,076	New	+$4.11M	0.18%	111
2025 Q2	–	Sell	-9,207	Closed	-$1.18M	–	1075
2025 Q1	$1.18M	Sell	9,207 -6,965	-43%	-$944K	0.05%	350
2024 Q4	$2.14M	Buy	+16,172	New	+$2.27M	0.09%	199
2024 Q3	–	Sell	-13,575	Closed	-$1.86M	–	1010
2024 Q2	$1.86M	Sell	13,575 -9,227	-40%	-$1.23M	0.09%	201
2024 Q1	$3.13M	Buy	22,802 +20,459	+873%	+$2.79M	0.17%	113
2023 Q4	$318K	Sell	2,343 -19,500	-89%	-$2.38M	0.01%	599
2023 Q3	$2.67M	Buy	+21,843	New	+$2.78M	0.13%	152
2023 Q2	–	Sell	-24,130	Closed	-$3.12M	–	971
2023 Q1	$3.12M	Buy	+24,130	New	+$3.16M	0.13%	122
2022 Q4	–	Sell	-13,123	Closed	-$1.53M	–	981
2022 Q3	$1.53M	Buy	+13,123	New	+$1.63M	0.08%	230
2021 Q4	–	Sell	-23,294	Closed	-$3.77M	–	905
2021 Q3	$3.77M	Buy	+23,294	New	+$3.92M	0.15%	119
2021 Q2	–	Sell	-15,846	Closed	-$2.44M	–	1019
2021 Q1	$2.39M	Buy	15,846 +8,986	+131%	+$1.43M	0.13%	159
2020 Q4	$1.04M	Sell	6,860 -28,238	-80%	-$4.04M	0.07%	231
2020 Q3	$4.75M	Buy	+35,098	New	+$4.76M	0.35%	54
2017 Q4	–	Sell	-2,361	Closed	-$263K	–	208
2017 Q3	$263K	Buy	+2,361	New	+$252K	0.03%	174
2017 Q2	–	Sell	-2,121	Closed	-$207K	–	273
2017 Q1	$207K	Buy	2,121 +1,863	+722%	+$178K	0.02%	289
2016 Q4	$23K	Sell	258 -42	-14%	-$3.82K	﹤0.01%	383
2016 Q3	$29K	Buy	+300	New	+$28.5K	﹤0.01%	301
2014 Q4	–	Sell	-8,748	Closed	-$798K	–	204
2014 Q3	$798K	Buy	+8,748	New	+$768K	0.1%	69

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Flow Traders U.S.'s IBB Position: Q1 2026 in Review

Flow Traders U.S. increased its iShares Biotechnology ETF (IBB) stake by 196% in Q1 2026, buying an estimated $2.34M and bringing the position to 20,708 shares worth $3.5M. The position accounts for 0.11% of the portfolio, ranked #155.

Flow Traders U.S. first reported a position in IBB in Q3 2014 and has held it in 20 quarters since. The position peaked at $4.75M in Q3 2020. 920 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Flow Traders U.S. held 20,708 shares of iShares Biotechnology ETF worth $3.5M as of Q1 2026.
Flow Traders U.S. bought 13,701 iShares Biotechnology ETF shares in Q1 2026, an estimated $2.34M.
iShares Biotechnology ETF made up 0.11% of Flow Traders U.S.'s portfolio in Q1 2026, its #155 holding.
Flow Traders U.S. first reported a position in iShares Biotechnology ETF in Q3 2014 and has held it in 20 quarters since.
Flow Traders U.S.'s iShares Biotechnology ETF position peaked at $4.75M in Q3 2020.
920 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Flow Traders U.S.'s 13F filing for Q1 2026, filed 15 May 2026.